Tech Company Financing Transactions

Interlace Medical Funding Round

Interlace Medical, based in Framingham, received $20.5 million in funding from Baird Capital, HLM Venture Partners and Aperture Venture Partners.

Transaction Overview

Company Name
Announced On
6/15/2009
Transaction Type
Venture Equity
Amount
$20,500,000
Round
Series C
Proceeds Purpose
The proceeds will be used to begin commercialization of the MyoSure� system, an easy-to-use, minimally invasive treatment to remove intrauterine fibroids and polyps.

Company Information

Company Status
Acquired or Merged
Industry
Medical Devices & Instruments
Mailing Address
139 Newbury Street
Framingham, MA 01701
USA
Email Address
Not Recorded
Overview
Interlace's mission is to improve the lives of women by delivering the most advanced medical devices in the world for treating gynecological diseases and conditions.
Profile
Interlace Medical LinkedIn Company Profile
Social Media
Interlace Medical Company Twitter Account
Company News
Interlace Medical News
Facebook
Interlace Medical on Facebook
YouTube
Interlace Medical on YouTube

Management Team

Title
Name
Email & Social
President
Bill Gruber
  Bill Gruber LinkedIn Profile  Bill Gruber Twitter Account  Bill Gruber News  Bill Gruber on Facebook


 

 

Browse more venture capital transactions:

Prev: 6/15/2009: Cappella venture capital transaction
Next: 6/15/2009: SS8 Networks venture capital transaction

 

Share this article

 


Where The Data Comes From

We record every notable VC transaction. All VC database entries on this site come from a variety of public sources. The information comes to us via our partnership with VentureDeal.com, an affiliated venture.

 


Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary